HIV in Canada: 2020 Surveillance highlights

Download in PDF format
(1.03 MB, 1 page)

Organization: Public Health Agency of Canada

Type: Infographic

Date published: 2021-12-01

ISBN: 978-0-660-39948-5

Cat.: HP40-292/1-2021E-PDF

Pub.: 210257

  • 1,639 new diagnosed cases of HIV in 2020 (21% decrease since 2019)
  • 71.4% of newly diagnosed cases were male
  • 28.6% of newly diagnosed cases were female

Key points

  • The COVID-19 pandemic resulted in a decreased demand for, and ability to provide, services related to sexually transmitted and bloodborne infections, including HIV testingFootnote 1. This may have had an impact on observed new diagnosis rates for HIV in 2020.
  • For most jurisdictions, data for 2020 exclude cases that have been previously diagnosed outside of Canada (e.g. prior to immigration) or in another province/territory.

New diagnosis rate per 100,000 population in 2020

  • National HIV diagnosis rate – 4.3
  • Provincial and territorial HIV diagnosis rates:
    • Territories – 2.3
    • British Columbia – 2.6
    • Alberta – 3.3
    • Saskatchewan – 15.7
    • Manitoba – 7.0
    • Ontario – 3.5
    • Quebec – 6.1Footnote *
    • Atlantic – 1.3

Reported new HIV cases by exposure category in adult males in 2020

  • Male-to-male sexual contact – 60.8%
  • Injection drug use – 12.8%
  • Male-to-male sexual contact and injection drug use – 3.0%
  • Heterosexual contact – 21.8%
  • Other – 1.6%Footnote

Reported new HIV cases by exposure category in adult females in 2020

  • Injection drug use – 32.7%
  • Heterosexual contact – 65.8%
  • Other – 1.5 %Footnote

Distribution of new HIV cases, by age group and sex

  • In males:
    • <15 years of age – 0.1 %
    • 15-19 years of age – 0.8%
    • 20-29 years of age –24.1%
    • 30-39 years of age – 32.1%
    • 40-49 years of age – 18.3%
    • ≥50 years of age – 24.6%
  • In females:
    • <15 years of age –0.2 %
    • 15-19 years of age – 3.4%
    • 20-29 years of age –25.5%
    • 30-39 years of age – 30.6%
    • 40-49 years of age – 18.4%
    • ≥50 years of age – 21.8%

Perinatal HIV in 2020

  • 250 infants exposed to HIV during pregnancy
  • 97.2% of HIV positive mothers received perinatal antiretroviral therapy (ART)
  • 5 infants were infected with HIV: 2 mothers had any ART, 2 had none, and the status of 1 mother was unknown
  • Based on sentinel surveillance representing 95% of exposed infants

Data Sources

HIV/AIDS Surveillance System (HASS) and Canadian Perinatal HIV Surveillance System (CPHSP)

Footnotes

Footnote *

QC rate includes previously diagnosed cases

Return to footnote * referrer

Footnote †

"Other" includes persons who were exposed during receipt of transfusion of blood or clotting factor or perinatal exposure.

Return to footnote referrer

Footnote 1

Survey of the impact of COVID-19 on the ability to provide STBBI prevention, testing and treatment including harm reduction services in Canada. PHAC. 2021.

Return to footnote 1 referrer

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: